Nektar Gets $90 Million Jury Award in Breach Suit Against Eli Lilly — Update

By Colin KellaherNektar Therapeutics said it has won a $90 million verdict in its lawsuit against Eli Lilly related to the development of its proposed autoimmune drug rezpegaldesleukin, or rezpeg.Nektar on Friday said a California jury found that Eli Lilly breached the implied covenant of good fait…